Theravance Biopharma Inc (TBPH):企業の財務・戦略的SWOT分析

◆英語タイトル:Theravance Biopharma Inc (TBPH) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH2442170FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:51
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥35,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥52,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Theravance Biopharma Inc (TBPH) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Theravance Biopharma Inc (Theravance Biopharma) is a biopharmaceutical company that discovers, develops, and markets organ-selective medicines for the treatment of inflammation and immune system disorders. The company is investigating its pipeline candidates for the treatment of asthma; neurogenic orthostatic hypotension (nOH); gastrointestinal motility disorders; ulcerative colitis; heart failure; chronic kidney disease (CKD); Crohn’s disease; gastroparesis and concurrent bacteremia. Its Yupelritm (revefenacin) obtained the US FDA approval for the treatment of chronic obstructive pulmonary disease (COPD) and is available in the US. The company has subsidiaries in the US, Ireland and the UK. Theravance Biopharma is headquartered in South San Francisco, California, the US.

Theravance Biopharma Inc Key Recent Developments

Feb 24,2021: Theravance Biopharma reports fourth quarter and full year 2020 financial results and provides business update
Feb 10,2021: Theravance Biopharma to Participate in Upcoming Investor Conferences
Nov 05,2020: Theravance Biopharma reports third quarter 2020 financial results and provides business update
Aug 06,2020: Theravance Biopharma reports second quarter 2020 financial results and provides business update
Jul 06,2020: Theravance Biopharma: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Theravance Biopharma Inc – Key Facts
Theravance Biopharma Inc – Key Employees
Theravance Biopharma Inc – Key Employee Biographies
Theravance Biopharma Inc – Major Products and Services
Theravance Biopharma Inc – History
Theravance Biopharma Inc – Company Statement
Theravance Biopharma Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Theravance Biopharma Inc – Business Description
Business Segment: Collaboration Revenue
Performance
Business Segment: Licensing Revenue
Performance
Business Segment: Product sales
Performance
Business Segment: Viatris Collaboration Agreement
Performance
Geographical Segment: Asia
Performance
Geographical Segment: Europe
Performance
Geographical Segment: The US
Performance
R&D Overview
Theravance Biopharma Inc – Corporate Strategy
Theravance Biopharma Inc – SWOT Analysis
SWOT Analysis – Overview
Theravance Biopharma Inc – Strengths
Theravance Biopharma Inc – Weaknesses
Theravance Biopharma Inc – Opportunities
Theravance Biopharma Inc – Threats
Theravance Biopharma Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Theravance Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Theravance Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Theravance Biopharma Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 24, 2021: Theravance Biopharma reports fourth quarter and full year 2020 financial results and provides business update
Feb 10, 2021: Theravance Biopharma to Participate in Upcoming Investor Conferences
Nov 05, 2020: Theravance Biopharma reports third quarter 2020 financial results and provides business update
Aug 06, 2020: Theravance Biopharma reports second quarter 2020 financial results and provides business update
Jul 06, 2020: Theravance Biopharma: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers
Jul 02, 2020: Theravance Biopharma appoints Deepika R. Pakianathan, Ph.D. to board of directors
May 06, 2020: Theravance Biopharma, reports first quarter 2020 financial results and provides business update
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Theravance Biopharma Inc, Key Facts
Theravance Biopharma Inc, Key Employees
Theravance Biopharma Inc, Key Employee Biographies
Theravance Biopharma Inc, Major Products and Services
Theravance Biopharma Inc, History
Theravance Biopharma Inc, Subsidiaries
Theravance Biopharma Inc, Key Competitors
Theravance Biopharma Inc, Ratios based on current share price
Theravance Biopharma Inc, Annual Ratios
Theravance Biopharma Inc, Annual Ratios (Cont...1)
Theravance Biopharma Inc, Interim Ratios
Theravance Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Theravance Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Theravance Biopharma Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Theravance Biopharma Inc (TBPH):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Shenzhen Topray Solar Co Ltd (002218):企業の財務・戦略的SWOT分析
    Shenzhen Topray Solar Co Ltd (002218) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Ethiopian Electric Power Corp:電力:M&Aディール及び事業提携情報
    Summary Ethiopian Electric Power Corp (Ethiopian Electric Power), formerly The Ethiopian Electric Light and Power Authority, is an electric utility that generates, transmits and distributes electricity. The utility maintains the Interconnected System and transmits electricity from hydropower plants …
  • Rowan Companies plc:企業の戦略・SWOT・財務情報
    Rowan Companies plc - Strategy, SWOT and Corporate Finance Report Summary Rowan Companies plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Strategic Resources Inc. (STI):企業の財務・戦略的SWOT分析
    Strategic Resources Inc. (STI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Hanwha Life Insurance Co Ltd:戦略・SWOT・企業財務分析
    Hanwha Life Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Hanwha Life Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Immatics Biotechnologies GmbH:企業の戦略的SWOT分析
    Immatics Biotechnologies GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Hydro One Networks Inc:電力:M&Aディール及び事業提携情報
    Summary Hydro One Networks Inc (Hydro One), a subsidiary of Hydro One Ltd, is an electric utility service provider. The company offers residential services, business services, rates and billing, saving money and energy, power outages and safety services. It provides move in move out, submit a meter …
  • Broadspectrum (Australia) Pty Ltd:企業の戦略的SWOT分析
    Broadspectrum (Australia) Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Tokuyama Corp (4043):電力:M&Aディール及び事業提携情報
    Summary Tokuyama Corp (Tokuyama), formerly Nihon Soda Kogyo Co., Ltd., manufactures and sells chemicals, specialty products and cement. Its product portfolio includes soda ash, caustic soda, silicon products, vinyl chloride monomer/polymer, fine chemicals, film products, medical materials, methylene …
  • Cerus Corp (CERS):医療機器:M&Aディール及び事業提携情報
    Summary Cerus Corp (Cerus) is a biomedical products company that focuses in the field of blood transfusion safety. It develops and commercializes the INTERCEPT Blood System to enhance blood safety. INTERCEPT Blood System reduces the risk of transfusion-transmitted infections by inactivating a wide r …
  • Hays plc (HAS):企業の財務・戦略的SWOT分析
    Hays plc (HAS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Republic Services Inc (RSG):企業の財務・戦略的SWOT分析
    Republic Services Inc (RSG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • LifeAssay Diagnostics (Pty) Ltd:企業の製品パイプライン分析2018
    Summary LifeAssay Diagnostics (Pty) Ltd (LifeAssay) is a medical device manufacturer. The company offers urine analysis, urine adulteration tests, lifestyle tests, lateral flow tests and industrial tests. It manufactures non-invasive semi-quantitative dipstick tests intended to measure selective phy …
  • Toshiba Corporation (6502):企業の財務・戦略的SWOT分析
    Toshiba Corporation (6502) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Galectin Therapeutics Inc (GALT)-医療機器分野:企業M&A・提携分析
    Summary Galectin Therapeutics Inc (Galectin Therapeutics), formerly Pro-Pharmaceuticals Inc is a biotechnology company that discovers, develops and commercializes therapies for fibrotic disease and cancer. The company's products comprise GR-MD-02 and GM-CT-01. Its GR-MD-02 is a drug candidate used f …
  • Cutispharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary CutisPharma Inc (CutisPharma) is a pharmaceutical company that develops and distributes kits. The company offers products such as oral suspensions, suppositories, oral solutions, and topical, among others. Its oral solutions and oral suspensions include mouthwashes, anti-microbial, and PPIs; …
  • Ansaldo STS SpA:企業の戦略・SWOT・財務情報
    Ansaldo STS SpA - Strategy, SWOT and Corporate Finance Report Summary Ansaldo STS SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Finox AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Finox AG (Finox), a subsidiary of Richter Gedeon Nyrt, is a drug development and manufacturing company that offers fertility treatment products. The company develops drugs in the field of fertility therapies. Its product portfolio includes biosimilars and patient friendly delivery devices. F …
  • Vivakor Inc (VIVK):企業の財務・戦略的SWOT分析
    Summary Vivakor Inc (Vivakor) is a technology and asset acquisition company that creates, acquires and accumulates distinct assets, intellectual properties, and various technologies. The company concentrates on precious metals extraction in the US. It also concentrates on oil extraction from shallow …
  • Binggrae Co., Ltd.:企業の戦略・SWOT・財務情報
    Binggrae Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Binggrae Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆